These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2987113)

  • 1. Subline divergence within L.C. Strong's C3H and CBA inbred mouse strains. A review.
    Whitmore AC; Whitmore SP
    Immunogenetics; 1985; 21(5):407-28. PubMed ID: 2987113
    [No Abstract]   [Full Text] [Related]  

  • 2. Titrations of various mouse mammary tumor viruses in different mouse strains.
    Moore DH; Charney J; Holben JA
    J Natl Cancer Inst; 1974 Jun; 52(6):1757-61. PubMed ID: 4365388
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural antibody in mammary tumor virus-infected mice that reacts with intracytoplasmic A particles of mouse mammary tumors.
    Zotter S; Müller M
    J Natl Cancer Inst; 1977 Apr; 58(4):967-75. PubMed ID: 191630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus oncogenesis and tumor immunogenicity in the mouse mammary tumor system.
    Vaage J; Medina D
    Cancer Res; 1974 Jun; 34(6):1319-24. PubMed ID: 4363654
    [No Abstract]   [Full Text] [Related]  

  • 5. Mammary tumor virus oncogenesis and tumor immunogenicity in three sublines of the C3H mouse.
    Vaage J; Medina D
    Cancer Res; 1978 Aug; 38(8):2443-7. PubMed ID: 208767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivity of C3H and RIII mammary tumor viruses in virgin female BALB/c mice.
    Squartini F; Bistocchi M
    J Natl Cancer Inst; 1977 Jun; 58(6):1845-7. PubMed ID: 194047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V beta 17 T-cell deletion by endogenous mammary tumor virus in wild-type-derived mouse strain.
    Jouvin-Marche E; Cazenave PA; Voegtle D; Marche PN
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3232-5. PubMed ID: 1314381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three mammary tumor viruses in genetically similar susceptible mice.
    Vlahakis G
    J Natl Cancer Inst; 1973 Nov; 51(5):1711-2. PubMed ID: 4357766
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. II. Genetic basis of the response of C3H mice.
    Steinmuller D; Tyler JD; David CS
    J Immunol; 1981 May; 126(5):1754-8. PubMed ID: 7217663
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetics of resistance to infection with Salmonella typhimurium in mice.
    Plant J; Glynn AA
    J Infect Dis; 1976 Jan; 133(1):72-8. PubMed ID: 1107437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.
    Ihle JN; Arthur LO; Fine DL
    Cancer Res; 1976 Aug; 36(8):2840-4. PubMed ID: 179709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of exogenous murine mammary tumor virus virulence in the C3H/HeJ mouse substrain bearing the Lps mutation.
    Outzen HC; Corrow D; Shultz LD
    J Natl Cancer Inst; 1985 Nov; 75(5):917-23. PubMed ID: 2997536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoelectron microscopic studies of antibodies in mouse sera directed against mouse mammary tumor virus.
    Miller MF; Dmochowski L; Bowen JM
    Cancer Res; 1977 Jul; 37(7 Pt 1):2086-91. PubMed ID: 193633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of MuLV-gs expression in crosses between high and low leukemia incidence strains.
    Hilgers J; Galesloot J
    Int J Cancer; 1973 May; 11(3):780-93. PubMed ID: 4364724
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of resistance to mammary tumor development in C57BL and I strains of mice. II. Inherent differences between the two strains.
    Nandi S
    J Natl Cancer Inst; 1974 Jun; 52(6):1797-804. PubMed ID: 4365389
    [No Abstract]   [Full Text] [Related]  

  • 16. Biologic characteristics of some mouse mammary tumor viruses.
    Moore DH; Holben JA; Charney J
    J Natl Cancer Inst; 1976 Oct; 57(4):889-96. PubMed ID: 187780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ir-LDHB: map position and functional analysis.
    Melchers I; Rajewsky K; Shreffler DC
    Eur J Immunol; 1973 Dec; 3(12):754-61. PubMed ID: 4781392
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of C3W mouse strain congenic to C3H/HeN at the newly defined minor H-42 histocompatibility locus.
    Kato H; Ishikawa H; Hino T; Suzuki H; Saito K
    Microbiol Immunol; 1986; 30(9):939-43. PubMed ID: 3796326
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-specific suppression of alloantibody responses of CBA mice injected with lymphoid cells from the MIs-antigen incompatible C3H X CBA hybrid.
    Lilliehöök B; Blomgren H
    Cell Immunol; 1978 Aug; 39(1):99-109. PubMed ID: 699061
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
    Boraschi D; Meltzer MS
    Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.